We are Immune Inc

Founded in 1961, National Technical Systems provides companies and government organizations throughout the world with process and product compliance services, technical resources, design engineering solutions and program management support. Its services include prototype development and evaluation, systems integration, marginal design, product life cycle support, project management, managed engineering, quality assurance and certification assistance services. National Technical Systems serves the aerospace, automotive, commercial products, defense, hardware and software, medical, nuclear and telecommunications markets. It has partnerships with MPR Associates, Yokogawa Corporation of America, Gems Sensors and Advanced Thermal Solutions. National Technical Systems maintains a location in Los Angeles.

Nesher Technologies (NTI) is a Los Angeles-based company that aims to revolutionize healthcare by developing sensitive and cost-effective diagnostic tools. They specialize in the patented Alternating Laser EXcitation (ALEX) technology, which allows for ultrasensitive and highly multiplexed detection and quantification of target molecules in complex samples. NTI's innovative platform has potential applications in various fields, including early cancer detection, neurodegenerative diseases, drug discovery, and more. With an exclusive license for the ALEX technology, NTI is focused on commercializing automated diagnostic tests that can detect multiple biomarkers, pathogens, and genetic aberrations simultaneously. Their research-grade prototype, the four-color ALEX single molecule fluorescence spectroscopy instrumentation, has already garnered attention in academia and received small business grants from the National Institutes of Health. NTI's mission is to empower clinicians and researchers with advanced analytical and diagnostic systems, ultimately improving disease detection and treatment outcomes.Generated from the website

Advances in Neuroblastoma Research Association (ANRA) is dedicated to the study and advancement of knowledge surrounding neuroblastoma, a prevalent childhood cancer affecting the peripheral nervous system. The organization facilitates biennial meetings that allow researchers and investigators to share insights on neuroblastoma biology, diagnosis, prognosis, and therapy. Since its inception, ANRA has organized a series of international conferences, including notable gatherings in cities like Paris, Los Angeles, and Amsterdam, allowing for a global exchange of research findings. The upcoming meeting in Washington, DC, scheduled for May 2025, continues the tradition of fostering collaboration among leading experts in the field. Generated from the website